ResMed Inc. logo
RMDResMed Inc.

Return on Assets (ROA): 17.30%

Is the return on assets (ROA) high or low?

The return on assets (ROA) of 17.30% is 23% above its 5-year average of 14.03%, near the high end of its 5-year range (10.04%–17.30%).

As of Friday, June 26, 2026. 8.13% above its 12-month average of 16.00%.

RMD Return on Assets (ROA)

RMD Return on Assets (ROA) Chart

17.14%

Annual fiscal-year return on assets; no daily interpolation.

+6.00% 10Y
RMD Return on Assets (ROA)

RMD Average Return on Assets (ROA) Chart

RMD Return on Assets (ROA)

RMD Current vs Average Return on Assets (ROA) Chart

RMD Return on Assets (ROA) Metrics

RETURN ON ASSETS (ROA)

17.30%

RETURN ON ASSETS (ROA) AVG TTM

16.00%

RETURN ON ASSETS (ROA) AVG 3Y

15.15%

RETURN ON ASSETS (ROA) AVG 5Y

14.03%

RETURN ON ASSETS (ROA) AVG 10Y

12.83%

RETURN ON ASSETS (ROA) AVG 15Y

12.77%

RETURN ON ASSETS (ROA) AVG 20Y

11.63%

CURRENT VS TTM AVG

+8.13%

CURRENT VS 3Y AVG

+14.21%

CURRENT VS 5Y AVG

+23.31%

CURRENT VS 10Y AVG

+34.79%

CURRENT VS 15Y AVG

+35.51%

CURRENT VS 20Y AVG

+48.73%

RMD Competitors' Return on Assets (ROA)

NAMEMARKET CAPRETURN ON ASSETS (ROA)TTM3Y5Y
ResMed Inc. (RMD)$28.93B17.30%16.00%15.15%14.03%
Veeva Systems Inc. (VEEV)vs ›$27.84B10.31%9.93%9.72%10.43%
DexCom, Inc. (DXCM)vs ›$26.76B14.03%11.04%9.26%8.83%
Biogen Inc. (BIIB)vs ›$31.39B4.65%5.11%6.74%8.29%
Moderna, Inc. (MRNA)vs ›$26.35B-27.80%-24.02%-10.32%-0.33%
IQVIA Holdings Inc. (IQV)vs ›$31.80B4.67%4.82%4.76%4.01%
Zoetis Inc. (ZTS)vs ›$32.07B17.44%17.37%16.33%15.33%
Mettler-Toledo International Inc. (MTD)vs ›$25.44B23.85%25.02%24.63%23.85%
Centene Corp. (CNC)vs ›$32.45B-7.94%-2.29%0.04%0.75%
Medline Inc. (MDLN)vs ›$32.87B2.47%3.17%1.75%1.75%

Asset Efficiency

ROA

17.3%

ROE

23.4%

Return on Assets (ROA) Formula & Definition

ROA = Net Income / Total Assets

Return on assets measures how efficiently a company generates profit from its total assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Return on Assets (ROA) FAQ

What is the return on assets (ROA) for ResMed Inc. (RMD)?
The return on assets (ROA) for RMD stock is 17.30%.
Is ResMed Inc.'s return on assets (ROA) high or low?
The return on assets (ROA) of 17.30% is 23% above its 5-year average of 14.03%, near the high end of its 5-year range (10.04%–17.30%).
What is the TTM average return on assets (ROA) for ResMed Inc. (RMD)?
The TTM average return on assets (ROA) for RMD stock is 16.00%.
What is the 3Y average return on assets (ROA) for ResMed Inc. (RMD)?
The 3Y average return on assets (ROA) for RMD stock is 15.15%.
What is the 5Y average return on assets (ROA) for ResMed Inc. (RMD)?
The 5Y average return on assets (ROA) for RMD stock is 14.03%.
What is the 10Y average return on assets (ROA) for ResMed Inc. (RMD)?
The 10Y average return on assets (ROA) for RMD stock is 12.83%.
What is the 15Y average return on assets (ROA) for ResMed Inc. (RMD)?
The 15Y average return on assets (ROA) for RMD stock is 12.77%.
What is the 20Y average return on assets (ROA) for ResMed Inc. (RMD)?
The 20Y average return on assets (ROA) for RMD stock is 11.63%.

RMD Return on Assets (ROA) History

DATERETURN ON ASSETS (ROA)
2025-06-3017.14%
2024-06-3014.86%
2023-06-3013.29%
2022-06-3015.30%
2021-06-3010.04%
2020-06-3013.55%
2019-06-309.85%
2018-06-3010.30%
2017-06-309.87%
2016-06-3010.81%
2015-06-3016.17%
2014-06-3014.62%
2013-06-3013.89%
2012-06-3011.92%
2011-06-3010.97%
2010-06-3011.69%
2009-06-309.71%
2008-06-307.85%
2007-06-305.30%
2006-06-308.76%
2005-06-308.37%
2004-06-3010.43%
2003-06-309.95%
2002-06-309.97%
2001-06-304.04%
2000-06-3019.23%
1999-06-3017.91%
1998-06-3016.41%
1997-06-3013.66%
1996-06-309.51%

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

San Diego, CA
9,980 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael J. Farrell